Royce & Associates’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,803
| Closed | -$209K | – | 923 |
|
|
2023
Q3 | $209K | Sell |
6,803
-117,579
| -95% | -$3.61M | ﹤0.01% | 873 |
|
|
2023
Q2 | $4.98M | Buy |
+124,382
| New | +$4.98M | 0.05% | 493 |
|
|
2021
Q2 | – | Sell |
-115,157
| Closed | -$8.07M | – | 1036 |
|
|
2021
Q1 | $8.07M | Sell |
115,157
-41,933
| -27% | -$2.94M | 0.05% | 501 |
|
|
2020
Q4 | $9.4M | Buy |
157,090
+3,647
| +2% | +$218K | 0.08% | 388 |
|
|
2020
Q3 | $9.23M | Sell |
153,443
-11,857
| -7% | -$713K | 0.1% | 303 |
|
|
2020
Q2 | $8.67M | Buy |
165,300
+164,426
| +18,813% | +$8.63M | 0.1% | 304 |
|
|
2020
Q1 | $29K | Buy |
874
+58
| +7% | +$1.92K | ﹤0.01% | 1072 |
|
|
2019
Q4 | $37K | Sell |
816
-244
| -23% | -$11.1K | ﹤0.01% | 1067 |
|
|
2019
Q3 | $40K | Buy |
+1,060
| New | +$40K | ﹤0.01% | 1075 |
|